Zhejiang Jingxin Pharmaceutical Co., Ltd.
SZSE:002020 Rapport sur les actions
Capitalisation boursière : CN¥11.1b
Ajouter à la liste de surveillanceZhejiang Jingxin Pharmaceutical Croissance future
Future contrôle des critères 1/6 Zhejiang Jingxin Pharmaceutical devrait augmenter ses bénéfices et son chiffre d'affaires de 14.4% et de 13.3% par an respectivement. Le BPA devrait croître de de 14.2% par an. Le rendement des capitaux propres devrait être 13.3% dans 3 ans.
Informations clés
14.4%
Taux de croissance des bénéfices
14.2%
Taux de croissance du BPA
Pharmaceuticals croissance des bénéfices 19.4% Taux de croissance des recettes 13.3% Rendement futur des capitaux propres 13.3% Couverture par les analystes Low
Dernière mise à jour 08 Nov 2024
Mises à jour récentes de la croissance future
Afficher toutes les mises à jour
Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.18 in 3Q 2023) Oct 25
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt Oct 04
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Sep 30
Investor sentiment improves as stock rises 21% Sep 30
Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement Sep 12
New minor risk - Earnings quality Aug 24
Now 21% overvalued Aug 16
Second quarter 2024 earnings released: EPS: CN¥0.27 (vs CN¥0.19 in 2Q 2023) Aug 15
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 15, 2024 Jun 29
Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30 May 21
Dividend of CN¥0.30 announced May 20
Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit Apr 08
Full year 2023 earnings: EPS misses analyst expectations Mar 31 Zhejiang Jingxin Pharmaceutical Co., Ltd., Annual General Meeting, Apr 22, 2024
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt Mar 29
Investor sentiment deteriorates as stock falls 16% Feb 05
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024 Dec 29
Third quarter 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.20 in 3Q 2022) Oct 27
Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.19 in 2Q 2022) Aug 15
New minor risk - Shareholder dilution Jul 07
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023 Jul 01
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2022 Final Profit Distribution Plan, Payable on 24 May 2023 May 19
Full year 2022 earnings released: EPS: CN¥0.73 (vs CN¥0.75 in FY 2021) Mar 02
Third quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.20 in 3Q 2021) Oct 28
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Directorate Appointments Oct 15
Investor sentiment improved over the past week Oct 14
Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.17 in 2Q 2021) Aug 26
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan, Payable on 25 May 2022 May 19
Zhejiang Jingxin Pharmaceutical Co., Ltd. Approves 2021 Profit Distribution Plan At the Annual General Meeting Held on April 22, 2022 Apr 27
High number of new directors Apr 27
Zhejiang Jingxin Pharmaceutical Co., Ltd., Annual General Meeting, Apr 22, 2022 Apr 02
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces the Final Profit Distribution Proposal for 2021 Mar 31
Full year 2021 earnings released: EPS: CN¥0.74 (vs CN¥0.82 in FY 2020) Mar 31
Investor sentiment improved over the past week Mar 24
Full year 2021 earnings: EPS misses analyst expectations Feb 27
Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.17 in 3Q 2020) Oct 28
Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.15 in 2Q 2020) Aug 27
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 28, 2021 May 22
First quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.13 in 1Q 2020) Apr 27
Full year 2020 earnings released: EPS CN¥0.98 (vs CN¥0.73 in FY 2019) Mar 30
Full year 2020 earnings released: EPS CN¥0.98 (vs CN¥0.73 in FY 2019) Mar 04
Earnings beat expectations, revenue disappoints Mar 04
New 90-day low: CN¥10.31 Dec 28
New 90-day low: CN¥10.72 Dec 12
New 90-day low: CN¥11.21 Nov 26
Third quarter earnings released Oct 28
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020 Oct 20
Earnings released Aug 25
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020 Aug 02
New 90-day high - CN¥15.10 Jul 30
Zhejiang Jingxin Pharmaceutical Co., Ltd. announced that it expects to receive CNY 499.999996 million in funding from Jingxin Holding Group Co., Ltd. Jul 21
Prévisions de croissance des bénéfices et des revenus SZSE:002020 - Estimations futures des analystes et données financières antérieures (CNY Millions ) Date Recettes Les revenus Flux de trésorerie disponible Cash from Op Moy. Nombre d'analystes 12/31/2026 5,740 963 978 1,208 5 12/31/2025 5,011 801 659 1,047 5 12/31/2024 4,422 693 N/A 849 5 9/30/2024 4,282 721 647 905 N/A 6/30/2024 4,212 705 546 856 N/A 3/31/2024 4,099 639 608 947 N/A 12/31/2023 3,999 619 273 793 N/A 9/30/2023 3,905 663 205 675 N/A 6/30/2023 3,844 681 534 995 N/A 3/31/2023 3,870 676 463 885 N/A 1/1/2023 3,780 662 340 856 N/A 9/30/2022 3,705 645 192 914 N/A 6/30/2022 3,613 630 -127 580 N/A 3/31/2022 3,480 616 -252 463 N/A 1/1/2022 3,467 613 -33 373 N/A 9/30/2021 3,384 720 -127 176 N/A 6/30/2021 3,344 708 9 377 N/A 3/31/2021 3,322 691 131 471 N/A 12/31/2020 3,258 653 179 513 N/A 9/30/2020 3,287 404 213 598 N/A 6/30/2020 3,429 420 85 424 N/A 3/31/2020 3,547 485 247 588 N/A 12/31/2019 3,647 520 198 535 N/A 9/30/2019 3,507 517 433 686 N/A 6/30/2019 3,394 482 482 675 N/A 3/31/2019 3,194 413 283 542 N/A 12/31/2018 2,944 369 270 523 N/A 9/30/2018 2,906 356 317 510 N/A 6/30/2018 2,629 307 N/A 381 N/A 3/31/2018 2,384 279 N/A 346 N/A 12/31/2017 2,219 264 N/A 385 N/A 9/30/2017 2,071 248 N/A 141 N/A 6/30/2017 1,982 231 N/A 339 N/A 3/31/2017 1,936 213 N/A 233 N/A 12/31/2016 1,875 200 N/A 253 N/A 9/30/2016 1,735 222 N/A 259 N/A 6/30/2016 1,613 209 N/A 168 N/A 3/31/2016 1,502 186 N/A 158 N/A 12/31/2015 1,416 166 N/A 145 N/A 9/30/2015 1,362 158 N/A 168 N/A 6/30/2015 1,335 143 N/A 169 N/A 3/31/2015 1,294 123 N/A 230 N/A 12/31/2014 1,235 107 N/A 210 N/A 9/30/2014 1,183 102 N/A 190 N/A 6/30/2014 1,112 90 N/A 175 N/A 3/31/2014 1,031 75 N/A 175 N/A 12/31/2013 974 64 N/A 111 N/A
Afficher plus
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 002020 ( 14.4% par an) est supérieure au taux d'épargne ( 2.8% ).
Bénéfices vs marché: Les bénéfices de 002020 ( 14.4% par an) devraient croître plus lentement que le marché CN ( 26.5% par an).
Croissance élevée des bénéfices: Les bénéfices de 002020 devraient augmenter, mais pas de manière significative .
Chiffre d'affaires vs marché: Le chiffre d'affaires de 002020 ( 13.3% par an) devrait croître plus lentement que le marché de CN ( 14.1% par an).
Croissance élevée des revenus: Le chiffre d'affaires de 002020 ( 13.3% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de 002020 devrait être faible dans 3 ans ( 13.3 %).
Découvrir les entreprises en croissance Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}